• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术技术和全身炎症影响结直肠癌肝转移切除术后的长期无病生存。

Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis.

作者信息

Gomez Dhanwant, Morris-Stiff Gareth, Wyatt Judy, Toogood Giles J, Lodge J Peter A, Prasad K Rajendra

机构信息

Hepatobiliary and Transplantation Unit, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.

出版信息

J Surg Oncol. 2008 Oct 1;98(5):371-6. doi: 10.1002/jso.21103.

DOI:10.1002/jso.21103
PMID:18646038
Abstract

BACKGROUND

To date, there is limited data available on prognostic factors that influence long-term disease-free survival following hepatic resection for colorectal liver metastasis (CRLM). The aim of the study was to identify prognostic factors that were associated with long-term disease-free survival (>5 years) following resection for CRLM.

METHODS

Patients undergoing resection for CRLM from January 1993 to March 2007 were identified from the hepatobiliary database. Data analyzed included demographics, laboratory results, operative findings and histopathological data.

RESULTS

Seven hundred five curative primary hepatic resections were performed, of which 434 patients developed disease recurrence within 5 years and 67 patients were disease-free more than 5 years. There was a significant association between systemic inflammatory response (raised neutrophil to lymphocyte ratio and/or C-reactive protein), blood transfusion, >2 tumors, bilobar disease and resection margin involvement with developing recurrence during the follow-up period. On multivariate analysis, three independent predictors for recurrent disease within the 5-year follow-up were identified: pre-operative inflammatory response; blood transfusion requirement; and status of resection margin.

CONCLUSION

Absence of a systemic inflammatory response and surgical technique to minimize transfusion requirements and obtain a R0 resection margin, are associated with long-term disease-free survival.

摘要

背景

迄今为止,关于影响结直肠癌肝转移(CRLM)肝切除术后长期无病生存的预后因素的数据有限。本研究的目的是确定与CRLM切除术后长期无病生存(>5年)相关的预后因素。

方法

从肝胆数据库中识别出1993年1月至2007年3月期间接受CRLM切除术的患者。分析的数据包括人口统计学、实验室检查结果、手术发现和组织病理学数据。

结果

共进行了705例根治性原发性肝切除术,其中434例患者在5年内出现疾病复发,67例患者无病生存超过5年。全身炎症反应(中性粒细胞与淋巴细胞比值升高和/或C反应蛋白升高)、输血、肿瘤>2个、双侧病变和切缘受累与随访期间疾病复发之间存在显著关联。多因素分析确定了5年随访期内疾病复发的三个独立预测因素:术前炎症反应;输血需求;切缘状态。

结论

无全身炎症反应以及采用尽量减少输血需求并获得R0切缘的手术技术,与长期无病生存相关。

相似文献

1
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis.手术技术和全身炎症影响结直肠癌肝转移切除术后的长期无病生存。
J Surg Oncol. 2008 Oct 1;98(5):371-6. doi: 10.1002/jso.21103.
2
Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.手术切缘对结直肠癌肝转移灶切除术后复发类型的影响:单中心经验
Surgery. 2008 Mar;143(3):384-93. doi: 10.1016/j.surg.2007.09.038. Epub 2007 Dec 21.
3
Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis.肝切除术治疗结直肠肝转移术后感染性并发症与长期预后的相关性。
Ann Surg. 2010 Jan;251(1):91-100. doi: 10.1097/SLA.0b013e3181bfda3c.
4
Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases.外科医生作为结直肠癌肝转移切除术后长期生存的一个变量的作用。
J Surg Oncol. 2009 Dec 1;100(7):538-45. doi: 10.1002/jso.21393.
5
Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis.结直肠癌肝转移切除术后早期疾病复发的预测因素。
Eur J Surg Oncol. 2007 Oct;33(8):1003-9. doi: 10.1016/j.ejso.2007.01.005. Epub 2007 Mar 9.
6
Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.接受肝切除术治疗结直肠癌肝转移患者的切缘:对1厘米规则的批判性评估
Eur J Surg Oncol. 2006 Jun;32(5):557-63. doi: 10.1016/j.ejso.2006.02.001. Epub 2006 Apr 3.
7
Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.结直肠癌肝转移的肝脏手术:10年随访结果。长期生存者、晚期复发及并发症的预后作用。
Ann Surg Oncol. 2008 Sep;15(9):2458-64. doi: 10.1245/s10434-008-9935-9. Epub 2008 May 8.
8
The extent of resection influences outcome following hepatectomy for colorectal liver metastases.切除范围影响结直肠癌肝转移肝切除术后的预后。
Eur J Surg Oncol. 2004 May;30(4):370-6. doi: 10.1016/j.ejso.2004.01.011.
9
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases.手术切缘大小不影响结直肠癌肝转移灶根治性肝切除术后的复发率。
Br J Surg. 2007 Sep;94(9):1133-8. doi: 10.1002/bjs.5762.
10
Survival after hepatic resection for colorectal metastases: a 10-year experience.结直肠癌肝转移灶切除术后的生存情况:十年经验总结
Ann Surg Oncol. 2006 May;13(5):668-76. doi: 10.1245/ASO.2006.05.039. Epub 2006 Mar 10.

引用本文的文献

1
Ranking as a Procedure for Selecting a Replacement Variable in the Score Predicting the Survival of Patients Treated with Curative Intent for Colorectal Liver Metastases.排序作为选择有治疗意向的结直肠癌肝转移患者生存评分预测替代变量的一种方法。
Medicina (Kaunas). 2023 Nov 15;59(11):2003. doi: 10.3390/medicina59112003.
2
Probe-based confocal laser endomicroscopy for real-time evaluation of colorectal liver metastasis in resected surgical specimens.基于探头的共聚焦激光内镜显微镜用于实时评估切除手术标本中的结直肠癌肝转移。
Hum Cell. 2023 Nov;36(6):2066-2073. doi: 10.1007/s13577-023-00965-9. Epub 2023 Aug 23.
3
Taiwan Society of Colon and Rectum Surgeons (TSCRS) Consensus for Anti-Inflammatory Nutritional Intervention in Colorectal Cancer.
台湾结肠直肠外科医师学会(TSCRS)关于结直肠癌抗炎营养干预的共识
Front Oncol. 2022 Jan 17;11:819742. doi: 10.3389/fonc.2021.819742. eCollection 2021.
4
Surgery-mediated tumor-promoting effects on the immune microenvironment.手术介导的对免疫微环境的肿瘤促进作用。
Semin Cancer Biol. 2022 Nov;86(Pt 3):408-419. doi: 10.1016/j.semcancer.2022.01.006. Epub 2022 Jan 20.
5
Novel Model to Predict the Prognosis of Patients with Stage II-III Colon Cancer.新型模型预测 II-III 期结肠癌患者的预后。
Biomed Res Int. 2020 Nov 22;2020:8812974. doi: 10.1155/2020/8812974. eCollection 2020.
6
Preoperative peripheral blood neutrophil count predicts long-term outcomes following hepatic resection for colorectal liver metastases.术前外周血中性粒细胞计数可预测结直肠癌肝转移肝切除术后的长期预后。
Oncol Lett. 2017 May;13(5):3688-3694. doi: 10.3892/ol.2017.5873. Epub 2017 Mar 17.
7
Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).转移性结直肠癌管理的临床实践指南:希腊医学肿瘤学家协会(HeSMO)共识声明
Ann Gastroenterol. 2016 Oct-Dec;29(4):390-416. doi: 10.20524/aog.2016.0050. Epub 2016 Jun 3.
8
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases.结直肠癌肝转移患者中基于转移结节数量的预后因素
Ann Coloproctol. 2016 Jun;32(3):92-100. doi: 10.3393/ac.2016.32.3.92. Epub 2016 Jun 30.
9
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值在结直肠癌肝转移中的预后意义:一项系统评价和荟萃分析
PLoS One. 2016 Jul 18;11(7):e0159447. doi: 10.1371/journal.pone.0159447. eCollection 2016.
10
Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma.围手术期输血是肝门部胆管癌积极手术切除后预后不良的一个因素。
J Gastrointest Surg. 2015 May;19(5):866-79. doi: 10.1007/s11605-014-2741-8. Epub 2015 Jan 21.